Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Forge Biologics, Inc

Clinical trials sponsored by Forge Biologics, Inc, explained in plain language.

Now part of Ajinomoto Co., Inc. 2802 TOKYO

Gene therapy contract development and manufacturing organization.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 2 Terminated 1

Gene therapy for krabbe disease: did it last?

Knowledge-focused Terminated

This study follows up on children with Krabbe disease who received a one-time gene therapy infusion (FBX-101) in earlier trials. Researchers will monitor safety and measure motor skills over time. Only 2 participants are enrolled, so results are very limited.

Sponsor: Forge Biologics, Inc • Aim: Knowledge-focused

Last updated Jun 26, 2026 13:47 UTC